World
Centanafadine Approved for ADHD in the United States, Unavailable in France
The United States has approved centanafadine, a new medication to treat attention-deficit/hyperactivity disorder (ADHD), according to Le Monde. The treatment features a mechanism of action described as innovative. It is not available in France. French specialists are warning about the limited number of medications available in the country to treat ADHD.